AN2 Therapeutics GAAP EPS of -$0.21 beats by $0.13
Source: SeekingAlpha
2025-08-12 16:37:41 ET
More on AN2 Therapeutics
- Seeking Alpha’s Quant Rating on AN2 Therapeutics
- Historical earnings data for AN2 Therapeutics
- Financial information for AN2 Therapeutics
Read the full article on Seeking Alpha
For further details see:
AN2 Therapeutics GAAP EPS of -$0.21 beats by $0.13
AN2 Therapeutics Inc.
NASDAQ: ANTX
ANTX Trading
-3.92% G/L:
$4.66 Last:
872,911 Volume:
$5.38 Open:
ANTX Latest News
March 09, 2026 03:02:18 pm
Power Hour Surge: Biotech Cash Floods, Energy Breakouts, and AI Bets Drive the Stocks to Watch into the Close
March 03, 2026 04:00:00 pm
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
February 17, 2026 07:00:00 am
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference
ANTX Stock Data
$30,142,226
20,699,489
1.32%
34
N/A
Biotechnology & Life Sciences
Healthcare
US
Menlo Park
